Jones Financial Companies
ABCL icon

Jones Financial Companies’s AbCellera Biologics ABCL Stock Holding History

Jones Financial Companies’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.93K Buy
1,507
+842
+127% +$3.03K ﹤0.01% 3848
2025
Q4 		$2.27K Sell
665
-35
-5% -$156 ﹤0.01% 3787
2025
Q3 		$3.32K Hold
700
– – ﹤0.01% 3524
2025
Q2 		$2.53K Buy
700
+500
+250% +$1.25K ﹤0.01% 3388
2025
Q1 		$462 Sell
200
-425
-68% -$1.22K ﹤0.01% 3518
2024
Q4 		$1.83K Sell
625
-300
-32% -$835 ﹤0.01% 3025
2024
Q3 		$2.41K Sell
925
-2,356
-72% -$6.53K ﹤0.01% 2635
2024
Q2 		$9.71K Hold
3,281
– – ﹤0.01% 1766
2024
Q1 		$14.9K Buy
+3,281
New +$16.7K ﹤0.01% 975

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return